Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The predictive factors of moral courage among hospital nurses.
Hakimi H, Mousazadeh N, Sharif-Nia H, Nazari R, Dehghani M. Hakimi H, et al. Among authors: mousazadeh n. Philos Ethics Humanit Med. 2023 Oct 18;18(1):13. doi: 10.1186/s13010-023-00141-9. Philos Ethics Humanit Med. 2023. PMID: 37848922 Free PMC article.
Combined Treatment of Dendrosomal-Curcumin and Daunorubicin Synergistically Inhibit Cell Proliferation, Migration and Induce Apoptosis in A549 Lung Cancer Cells.
Eslami SS, Jafari D, Ghotaslou A, Amoupour M, Asri Kojabad A, Jafari R, Mousazadeh N, Tarighi P, Sadeghizadeh M. Eslami SS, et al. Among authors: mousazadeh n. Adv Pharm Bull. 2023 Jul;13(3):539-550. doi: 10.34172/apb.2023.050. Epub 2022 Jul 2. Adv Pharm Bull. 2023. PMID: 37646049 Free PMC article.
Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapy.
Salehiabar M, Ghaffarlou M, Mohammadi A, Mousazadeh N, Rahimi H, Abhari F, Rashidzadeh H, Nasehi L, Rezaeejam H, Barsbay M, Ertas YN, Nosrati H, Kavetskyy T, Danafar H. Salehiabar M, et al. Among authors: mousazadeh n. J Control Release. 2023 Jan;353:850-863. doi: 10.1016/j.jconrel.2022.12.004. Epub 2022 Dec 17. J Control Release. 2023. PMID: 36493951
Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer.
Nosrati H, Ghaffarlou M, Salehiabar M, Mousazadeh N, Abhari F, Barsbay M, Ertas YN, Rashidzadeh H, Mohammadi A, Nasehi L, Rezaeejam H, Davaran S, Ramazani A, Conde J, Danafar H. Nosrati H, et al. Among authors: mousazadeh n. Biomater Adv. 2022 Sep;140:213090. doi: 10.1016/j.bioadv.2022.213090. Epub 2022 Aug 22. Biomater Adv. 2022. PMID: 36027669
19 results